We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Biogen, Stakeholders, Advocacy Group React to CMS Aduhelm Coverage Decision
Biogen, Stakeholders, Advocacy Group React to CMS Aduhelm Coverage Decision
Could Biogen sidestep the Centers for Medicare and Medicaid Services (CMS) coverage decision that threatens to topple its longed-for Alzheimer’s treatment franchise?